BridgeBio Pharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Palo Alto, CA
BBIO chart
What traders are saying about $BBIO
Latest postsBridgeBio Pharma, Inc. news
- BlackRock reports sole voting power over 9.58 million BridgeBio Pharma (BBIO) shares.
Stock Titan ·
- BridgeBio Pharma, Inc. expected to post a loss of 59 cents a share - Earnings Preview
TradingView ·
- BridgeBio Pharma (NasdaqGS:BBIO) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- BridgeBio Pharma, Inc. Estimates – NASDAQ:BBIO
TradingView ·
- How Investors May Respond To BridgeBio Pharma (BBIO) Positive Drug Data
Simply Wall Street ·
- BridgeBio Pharma Inc. (US10806X1028.SG) insider ownership and holdings
Yahoo Finance Australia ·
- BridgeBio Pharma will report Q3 2026 results and issue business update: Can BBIO break above $69?
Traders Union ·
- BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET
Yahoo Finance ·
- BridgeBio Pharma (NDQ:BBIO): 5 Years From A Near-Death Experience, Its Has A Cumulative Opportunity Of ~$30bn At Its Fingertips!
Stocks Down Under ·
- The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics
Yahoo Finance ·
- What BridgeBio Pharma Doubters Missed
Yahoo Finance ·
- 4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
Yahoo Finance ·
BridgeBio Pharma, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $502.1M | $221.9M | $9.3M | $77.6M |
| Diluted EPS | $-3.78 | $-2.88 | $-3.95 | $-3.26 |
| Total assets (year end) | $936.0M | $919.3M | $546.4M | $623.0M |
| Cash and equivalents (year end) | $570.1M | $681.1M | $375.9M | $376.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BridgeBio Pharma, Inc.
- Ticker
- BBIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Palo Alto, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1743881
- Former names
- BridgeBio Pharma LLC
Frequently asked questions
What exchange is BridgeBio Pharma, Inc. listed on?
BridgeBio Pharma, Inc. trades on the Nasdaq under the ticker symbol BBIO.
What industry is BridgeBio Pharma, Inc. in?
BridgeBio Pharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is BridgeBio Pharma, Inc. headquartered?
BridgeBio Pharma, Inc.'s business address on file with the SEC is in Palo Alto, CA.
When does BridgeBio Pharma, Inc.'s fiscal year end?
BridgeBio Pharma, Inc.'s fiscal year ends on December 31.
How much revenue did BridgeBio Pharma, Inc. report?
BridgeBio Pharma, Inc. reported $502.1M in revenue for calendar year 2025, according to its SEC filings.